In summary, EVs derived from colorectal CSCs carry oncogenic miR‐200c and act as a messenger to enable the horizontal transfer of metastatic properties to CRC cells, thereby enhancing their stemness maintenance and invasive capability via PI3K/AKT/mTOR activation. This evidence concerns the gene MTOR and colorectal carcinoma.